The Organ On A Chip Market is driven by Rise in Investments for R&D Activities

Organ-on-a-chip technology provides an interactive microsystem that mimics the physiological functions of human organs. It contains microfluidic cell cultures embedded in a solid polymeric chip that simulates tissue- and organ-level activities and functions. This technology allows researchers to study normal and disease processes in human organs and tissues by providing a physiologically relevant microenvironment. The increasing investment in research and development activities to develop advanced organ-on-chip models is a key factor fueling the growth of the organ-on-a-chip market. For instance, according to the Alliance for Regenerative Medicine, in 2020 investments in regenerative medicine amounted to US$ 9.7 billion globally, indicating rising focus on developing innovative healthcare technologies.

The global Organ On A Chip Market is estimated to be valued at US$ 228.24 Mn in 2023 and is expected to exhibit a CAGR of 3.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Microphysiological systems are becoming more prevalent in drug development and basic research applications due to their ability to mimic human organ functions in a microfluidic chip format. Development of multi-organ chip systems enables reproduction of inter-organ communication and systemic responses, providing more physiologically relevant models compared to single organ chips. For instance, in January 2021, researchers from the University of California developed a kidney on a chip integrated with a body on a chip system to study drug-induced kidney injury in a human body-like context. Such advancement towards physiologically relevant and complex multi-organ models will continue to drive market growth over the forecast period.

Porter's Analysis
Threat of new entrants:Low explanation- High capital requirements and presence of established players make entry difficult in this niche market.

Bargaining power of buyers: Medium explanation- Presence of substitutes provides moderate bargaining power to buyers.

Bargaining power of suppliers: Medium explanation- Few incumbents control key technologies providing some pricing power to suppliers.

Threat of new substitutes: Medium explanation- Ongoing research in alternatives like tissue/blood vessel chips pose moderate threat.

Competitive rivalry: High explanation- Technology intensity and focus on innovation leads to intense competition.

Key Takeaways
The Global Organ On A Chip Market Size is expected to witness high growth. The global Organ On A Chip Market is estimated to be valued at US$ 228.24 Mn in 2023 and is expected to exhibit a CAGR of 3.1% over the forecast period 2023 to 2030.

Regional analysis related content comprises Western Europe and North America dominate the market currently due to high R&D investments. However, Asia Pacific is expected to witness fastest growth due to increasing government funding for life science research in countries like China and India.

Key players related content comprises Key players operating in the Organ On A Chip market are Ball Corporation,,Crown Holdings, Inc.,,Trivium Packaging B.V.,,Mauser Packaging Solutions,,CCL Containers. These players are focusing on new product launches and partnerships to strengthen their market position.

 

Get more insights on this topic:
https://www.rapidwebwire.com/organ-on-a-chip-market-demand/

Explore more trending article:
https://www.dailyprbulletin.com/organ-on-a-chip-market-size/

Check below trending articles:
https://www.marketwebjournal.com/organ-on-a-chip-market-insights/